1. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation
   Wenhui Ma et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
2. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma
   Amany Selim Attia et al, 2024, Cancer Biomarkers CrossRef
3. Stomatin-like protein 2 of turbot Scopthalmus maximus: Gene cloning, expression profiling and immunoregulatory properties
   Heng Chi et al, 2016, Fish & Shellfish Immunology CrossRef
4. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer
   Chung-Wei Fan et al, 2017, Clinica Chimica Acta CrossRef
5. miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma
   XUAN YANG et al, 2015, International Journal of Oncology CrossRef
6. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs
   Zebing Liu et al, 2015, Clinical Cancer Research CrossRef
7. Stomatin-like Protein 2 Promotes Tumor Cell Survival by Activating the JAK2-STAT3-PIM1 Pathway, Suggesting a Novel Therapy in CRC
   Qiang Liu et al, 2020, Molecular Therapy - Oncolytics CrossRef
8. Stomatin‐like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high‐risk clinicopathological parameters and BRAFV600E mutation
   Aleksandar Bartolome et al, 2016, APMIS CrossRef
9. Stomatin-like protein-2 confers neuroprotection effect in oxygen-glucose deprivation/reoxygenation-injured neurons by regulating AMPK/Nrf2 signalling
   Minjuan Wang et al, 2020, Journal of Drug Targeting CrossRef
10. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma
    Xueyang Yang et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef